POLYMERIC CONJUGATES AND USES THEREOF
    42.
    发明申请
    POLYMERIC CONJUGATES AND USES THEREOF 审中-公开
    聚合物共轭物及其用途

    公开(公告)号:WO2017145164A1

    公开(公告)日:2017-08-31

    申请号:PCT/IL2017/050236

    申请日:2017-02-24

    CPC classification number: A61K9/5153 A61K47/645

    Abstract: Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.

    Abstract translation: 包含聚合物基质的聚合物缀合物,所述聚合物基质具有与其相关的下调与黑素瘤的发作或进展相关的多肽的活性或表达的试剂,以及任选且优选地,协同作用的另外的试剂 与所述代理商一起提供。 还提供了用于制备这些缀合物的合成方法及其在治疗黑素瘤和其他癌症疾病中的用途。

    음이온성 약물을 함유하는 고분자 미셀의 제조방법
    46.
    发明申请
    음이온성 약물을 함유하는 고분자 미셀의 제조방법 审中-公开
    制备含有阴离子药物的聚合物胶束的方法

    公开(公告)号:WO2017105138A1

    公开(公告)日:2017-06-22

    申请号:PCT/KR2016/014821

    申请日:2016-12-16

    CPC classification number: A61K9/00 A61K9/107 A61K31/7088 A61K47/14 A61K47/30

    Abstract: 본 발명은 수상에서 음이온성 약물과 양이온성 화합물을 정전기적 결합을 이용하여 나노입자를 형성시키는 단계; 및 상기 나노입자를 양친성 고분자 및 임의로 폴리락트산염으로 이루어진 고분자 미셀 안에 포함시키는 단계를 포함함으로써, 정전기적 결합과 소수성 결합을 증가시켜 제형의 음이온 약물 봉입률을 높임으로써 음이온성 약물 전달용 조성물의 제조 수득률을 증가시키는 제조 방법에 관한 것이다.

    Abstract translation:

    本发明包括使用静电耦合到阴离子药物和在水中以形成纳米颗粒中的阳离子化合物的工序; 和纳米颗粒的两亲性聚合物和任选的用于通过包括包含在由乳酸盐,静电耦合,并通过增加阴离子药物递送组合物的制剂中的阴离子性药物包封率,以增加疏水性结合的聚合物胶束的步骤的聚 用于提高产量的生产方法。

    PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL DELIVERY
    47.
    发明申请
    PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL DELIVERY 审中-公开
    用于透皮递送的药物组合物

    公开(公告)号:WO2017072774A1

    公开(公告)日:2017-05-04

    申请号:PCT/IL2016/051167

    申请日:2016-10-28

    Applicant: SOLUBEST LTD

    Abstract: The present application relates to a pharmaceutical composition for transmucosal administration of an active lipophilic compound through the oral mucosa comprising a lipophilic active compound, a polymeric matrix formed by two or more water-soluble polymers and a rapid dissolution agent. At least one of the water-soluble polymers is an amphiphilic polymer and at least one is either a hydrophilic polymer or an amphiphilic polymer with a hydrophobic-hydrophilic balance different from the first amphiphilic polymer. In addition, the polymeric matrix is not crosslinked and no covalent interaction occurs between the two or more polymers and between the polymers and the lipophilic active compound, which is interwoven with the aforesaid polymeric matrix.

    Abstract translation: 本申请涉及通过口腔粘膜透粘膜给予活性亲脂性化合物的药物组合物,其包含亲脂性活性化合物,由两种或更多种水溶性聚合物形成的聚合物基质和快速溶解 剂。 至少一种水溶性聚合物是两亲聚合物,并且至少一种是亲水聚合物或具有不同于第一种两亲聚合物的疏水 - 亲水平衡的两亲聚合物。 此外,聚合物基质不交联,并且在两种或更多种聚合物之间以及聚合物与与上述聚合物基质交织的亲脂性活性化合物之间不发生共价相互作用。

Patent Agency Ranking